Denileukin diftitox Withdrawn Phase 2 Trials for Anaplastic Large-Cell Lymphoma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00801918Denileukine Diftitox for Relapsed ALCL